Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2020-06-29 (5 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: LUITRE-DOMPIERRE (35133), Ille-et-Vilaine
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE LUITRE-DOMPIERRE : revenue, balance sheet and financial ratios
PHARMACIE LUITRE-DOMPIERRE is a French company
founded 5 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in LUITRE-DOMPIERRE (35133),
this company of category PME
shows in 2024 a net income positive of 44 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE LUITRE-DOMPIERRE (SIREN 884629205)
Indicator
2024
2023
2022
2021
Revenue
N/C
N/C
N/C
N/C
Net income
44 347 €
18 094 €
62 035 €
46 640 €
EBITDA
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE LUITRE-DOMPIERRE generates positive net income of 44 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2021-2024: 47 k€ -> 44 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
44 347 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 118%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 38%. The balance between equity and debt is satisfactory.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
117.609%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
37.867%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2021
2022
2023
2024
Debt ratio
491.328
229.055
172.725
117.609
Financial autonomy
14.509
25.247
29.488
37.867
Repayment capacity
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
Sector positioning
Debt ratio
117.612024
2022
2023
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Average-10 pts over 3 years
In 2024, the debt ratio of PHARMACIE LUITRE-DOMPIERRE (117.61) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
37.87%2024
2022
2023
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Average+11 pts over 3 years
In 2024, the financial autonomy of PHARMACIE LUITRE-DOMPIERRE (37.9%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 281.02. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2021
2022
2023
2024
Liquidity ratio
329.917
302.15
259.252
281.018
Interest coverage
None
None
None
None
Sector positioning
Liquidity ratio
281.022024
2022
2023
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Excellent
In 2024, the liquidity ratio of PHARMACIE LUITRE-DOMPIERRE (281.02) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Positioning of PHARMACIE LUITRE-DOMPIERRE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE LUITRE-DOMPIERRE is estimated at
619 116 €
(range 431 143€ - 926 234€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
431k€619k€926k€
619 116 €Range: 431 143€ - 926 234€
NAF 5 année 2024
Valuation method used
Net Income Multiple
44 347 €
×
14.0x
=619 117 €
Range: 431 143€ - 926 234€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE LUITRE-DOMPIERRE with other companies in the same sector:
Frequently asked questions about PHARMACIE LUITRE-DOMPIERRE
What is the revenue of PHARMACIE LUITRE-DOMPIERRE ?
The revenue of PHARMACIE LUITRE-DOMPIERRE is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE LUITRE-DOMPIERRE profitable?
Yes, PHARMACIE LUITRE-DOMPIERRE generated a net profit of 44 k€ in 2024.
Where is the headquarters of PHARMACIE LUITRE-DOMPIERRE ?
The headquarters of PHARMACIE LUITRE-DOMPIERRE is located in LUITRE-DOMPIERRE (35133), in the department Ille-et-Vilaine.
Where to find the tax return of PHARMACIE LUITRE-DOMPIERRE ?
The tax return of PHARMACIE LUITRE-DOMPIERRE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE LUITRE-DOMPIERRE operate?
PHARMACIE LUITRE-DOMPIERRE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart